Abstract

The aim is to study the effectiveness of lithium chloride for preventing damage to the monolayer of endothelial cells in vitro exposed to serum of patients with septic shock. Material and methods. Serum samples prepared from blood of 5 septic shock patients selected according to «Sepsis-3» criteria and 5 healthy volunteers (control serum) were used in the study. Blood for experiments was withdrawn within 2 hours after the diagnosis of septic shock. The Ea.hy926 endothelial cells were incubated with the serum of a patient with septic shock (toxic serum) or control serum for 3 hours at 37°C without or with lithium chloride at final concentrations of 0.01 mmol/l, 0.1 mmol/l, 1 mmol/l, 10 mmol/l. Lithium chloride was added 1 hour before the serum change. After incubation, the expressions of actin, VE-cadherin and claudin were assessed by immunofluorescent microscopy; the level and degree of phosphorylation of glycogen synthase kinase 3/1 (GSK-3/3) were determined using western blotting. Results. Toxic serum significantly inhibited GSK-3/3 phosphorylation, induced cleavage of VE-cadherin and reduced the claudin inendothelial cells. Toxic serum also altered the shape of endothelial cells: they lost their native polygonal shape and became elongated with gaps between them. Incubation of endothelial cells monolayer with lithium chloride at concentrations equal or higher 1.0 mmol/l almost completely prevented cleavage of claudin, actin and VE-cadherin. When studying the in vitro protection of endothelial cells from effects of toxic serum with lithium chloride, pre-incubation with the drug at a concentration of 1 mmol/l for 1 hour prevented inactivation (dephosphorylation) of GSK-3/3 and even to stimulate its phosphorylation in 1-4 hours after exposure to the serum. Conclusion. The study clearly showed the protective effect of lithium chloride on endothelial cell monolayer by activating phosphorylation of GSK-3/3 (enzyme conversion into inactive form). Moreover, the effect of lithium chloride exhibited a distinct dose-dependent character starting with a concentration of 0.01 mmol/l.

Highlights

  • Lithium preparations have been successfully used for many years in psychiatry to treat bipolar disorders [1]

  • The study clearly showed the protective effect of lithium chloride on endothelial cell monolayer by activating phosphorylation of glycogen synthase kinase 3β (GSK-3β)

  • Since GSK-3β kinase is the main signal molecule involved in the damage of many cell types, including endothelial cells, we investigated the effect of toxic serum on the phosphorylation level of this kinase

Read more

Summary

Introduction

Lithium preparations have been successfully used for many years in psychiatry to treat bipolar disorders [1]. Later the lithium effects were confirmed using the Langendorff perfusion heart [4] and in vivo myocardial infarction model in rats [5] In this connection, a recent study [6] that employed modeling the cardiac arrest according to method by V. The use of LiCl was associated with an increase in the number of viable hippocampal neurons in resuscitated rats by 37% in the CA1 field (P

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.